Literature DB >> 2411815

Recognition of viral antigens by human influenza A virus-specific T lymphocyte clones.

B Fleischer, H Becht, R Rott.   

Abstract

The nature of the viral antigens recognized by influenza A virus-immune cytotoxic T lymphocytes (CTL) is still a matter of debate. We have used four human influenza A virus-specific T lymphocyte clones with antigen-specific cytotoxic and proliferative activity to investigate the requirements for recognition of viral antigens on infected cells. One clone recognized a cross-reactive determinant on the viral hemagglutinin, and two clones were specific for different epitopes on the viral nucleoprotein (NP). A fourth clone seemed to be specific for the viral M protein. Target cell recognition was abrogated by the addition, during infection, of the lysosomotropic drug chloroquine, known to inhibit antigen processing. Furthermore, target cells that had been pulsed with soluble purified NP were recognized and were lysed by the NP-specific clone. This reaction could also be abrogated by the addition of chloroquine during pulsing. These results were obtained irrespective of whether EBV-transformed B lymphoblastoid cells or Ia antigen-expressing T cell blasts were used as target cells. It is concluded that CTL can recognize internal viral proteins that are actively presented at the surface of the target cell. These data indicate that probably every viral protein can function as a target molecule for virus-immune CTL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411815

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells.

Authors:  S Jacobson; R P Sekaly; C L Jacobson; H F McFarland; E O Long
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

2.  N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells.

Authors:  L Puddington; M J Bevan; J K Rose; L Lefrançois
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

Review 3.  Recognition of influenza virus proteins by cytotoxic T lymphocytes.

Authors:  A R Townsend
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.

Authors:  M Chen; M Shirai; Z Liu; T Arichi; H Takahashi; M Nishioka
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.

Authors:  G J Gorse; R B Belshe
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

6.  Tat-mediated protein delivery can facilitate MHC class I presentation of antigens.

Authors:  P Moy; Y Daikh; B Pepinsky; D Thomas; S Fawell; J Barsoum
Journal:  Mol Biotechnol       Date:  1996-10       Impact factor: 2.695

7.  Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Authors:  J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  Characterization of cell mediated immune responses to the hepatitis B core protein in man.

Authors:  S P Sylvan; U B Hellström; B Flehmig
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

9.  Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus.

Authors:  Quanjiao Chen; Haimen Kuang; Huadong Wang; Fang Fang; Zhongdong Yang; Zhiping Zhang; Xianen Zhang; Ze Chen
Journal:  Virus Genes       Date:  2008-12-10       Impact factor: 2.332

10.  Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.

Authors:  Katherine A Richards; Francisco A Chaves; Frederick R Krafcik; David J Topham; Christopher A Lazarski; Andrea J Sant
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.